OrbiMed’s Chimerix, Inc. CMRX Stock Holding History

OrbiMed’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,021,600	Closed	-$39M	–	135
2015 Q3	$39M	Hold	1,021,600	–	–	0.39%	52
2015 Q2	$47.2M	Buy	+1,021,600	New	+$40.9M	0.39%	56

Other funds holding CMRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

OrbiMed's CMRX Position: Q4 2015 in Review

OrbiMed sold out of Chimerix, Inc. (CMRX) in Q4 2015, closing a stake of 1,021,600 shares — an estimated $39M sold.

OrbiMed first reported a position in CMRX in Q2 2015 and held it in 2 quarters. The position peaked at $47.2M in Q2 2015. 140 funds tracked by Wall St. Rank hold CMRX as of Q4 2015.

OrbiMed reported no remaining Chimerix, Inc. position as of Q4 2015 after selling out during the quarter.
OrbiMed sold 1,021,600 Chimerix, Inc. shares in Q4 2015, an estimated $39M.
OrbiMed first reported a position in Chimerix, Inc. in Q2 2015 and held it in 2 quarters.
OrbiMed's Chimerix, Inc. position peaked at $47.2M in Q2 2015.
140 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2015.

Based on OrbiMed's 13F filing for Q4 2015, filed 16 Feb 2016.